Iris Pharma

A leading contract research organization (CRO) dedicated to ophthalmology, Iris Pharma helps clients around the world navigate every stage of the drug and device development process including in vivo screening, proof of concept, ocular efficacy, GLP preclinical studies, bioanalysis, clinical trials, and marketing surveys. Iris Pharma has partnered with clients to bring more than 70 ocular drugs and medical devices to market in the past 34 years, in addition to offering consulting services to help clients determine the best indication for molecules and products in development. This CRO has expertise in all ophthalmic indications, and supports clients ranging from small start-ups to large pharmaceutical companies in moving forward products that directly or indirectly affect eye health.

Medical devices

Medicine

6,400.00 K€

Bioanalyse Histologie

Des solutions pour tous les défis liés au développement de médicaments oculaires et dispositifs médicaux ophtalmiques.